Postprandial concentrations and distribution of apo C-III in type 2 diabetic patients. Effect Of bezafibrate treatment (Q73575764)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729394 AND SRC:MED&resulttype=core&format=json

5 November 2019

title

Postprandial concentrations and distribution of apo C-III in type 2 diabetic patients. Effect Of bezafibrate treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729394 AND SRC:MED&resulttype=core&format=json

5 November 2019

author name string

N Attia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729394 AND SRC:MED&resulttype=core&format=json

5 November 2019

V Durlach

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729394 AND SRC:MED&resulttype=core&format=json

5 November 2019

M Cambilleau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729394 AND SRC:MED&resulttype=core&format=json

5 November 2019

D Roche

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729394 AND SRC:MED&resulttype=core&format=json

5 November 2019

A Girard-Globa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729394 AND SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729394 AND SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729394 AND SRC:MED&resulttype=core&format=json

5 November 2019

volume

149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729394 AND SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729394 AND SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

427-433

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729394 AND SRC:MED&resulttype=core&format=json

Fibric acids: effects on lipids and lipoprotein metabolism

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Effect of bezafibrate on lipoprotein secretion by cultured human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Effect of clofibrate on postheparin plasma triglyceride lipase activities in patients with hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Apolipoprotein C-II and C-III levels in hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Hypertriglyceridaemia associated with an abnormal triglyceride-rich lipoprotein carrying excess apolipoprotein C-III-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Alimentary lipemia: plasma high-density lipoproteins and apolipoproteins CII and CIII in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Post-prandial metabolism of triglyceride-rich lipoproteins in non-insulin-dependent diabetic patients before and after bezafibrate treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Analysis of serial measurements in medical research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

Quantitative determination of human apolipoprotein C-III by electroimmunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(99)00337-8

10.1016/S0021-9150(99)00337-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10729394 AND SRC:MED&resulttype=core&format=json

5 November 2019

1 reference